Nouveau Life Pharmaceuticals, Inc. (OTCPK:NOUV) agreed to acquire cannabis cultivation business from Puration, Inc. (OTCPK:PURA) for $1.2 million on October 4, 2018. Nouveau has issued convertible purchase note as a part of consideration. Post recapitalization of Nouveau and Puration issued purchase note will be converted into a number of common NOUV shares sufficient to issue one NOUV common share for every five shares of PURA common shares issued and outstanding. As of June 12, 2020, Puration is unwinding that deal and moving forward with a new deal structured to include resolving the delayed issue of a planned dividend to PURA shareholders. 

Nouveau Life Pharmaceuticals, Inc. (OTCPK:NOUV) cancelled the acquisition of cannabis cultivation business from Puration, Inc. (OTCPK:PURA) on July 17, 2020.